Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Nephrology
Volume 2015, Article ID 316863, 5 pages
http://dx.doi.org/10.1155/2015/316863
Case Report

A Case of Concurrent MPO-/PR3-Negative ANCA-Associated Glomerulonephritis and Membranous Glomerulopathy

1Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan
2Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan

Received 6 October 2014; Accepted 21 December 2014

Academic Editor: Aikaterini Papagianni

Copyright © 2015 Yasuyuki Nakada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Bosch, A. Guilabert, and J. Font, “Antineutrophil cytoplasmic antibodies,” The Lancet, vol. 368, no. 9533, pp. 404–418, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. H. K. Choi, P. A. Merkel, A. M. Walker, and J. L. Niles, “Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis,” Arthritis & Rheumatology, vol. 43, no. 2, pp. 405–413, 2000. View at Google Scholar
  3. S. L. Hogan, K. E. Muller, J. C. Jennette, and R. J. Falk, “A review of therapeutic studies of idiopathic membranous glomerulopathy,” The American Journal of Kidney Diseases, vol. 25, no. 6, pp. 862–875, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. S. H. Nasr, S. M. Said, A. M. Valeri et al., “Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 2, pp. 299–308, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. O. Wiesner, K. A. Russell, A. S. Lee et al., “Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis,” Arthritis & Rheumatism, vol. 50, no. 9, pp. 2954–2965, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. Seidowsky, M. Hoffmann, S. Ruben-Duval et al., “Elastase-ANCA-associated idiopathic necrotizing crescentic glomerulonephritis—a report of three cases,” Nephrology Dialysis Transplantation, vol. 22, no. 7, pp. 2068–2071, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. H. Schultz, J. Weiss, S. F. Carroll, and W. L. Gross, “The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies,” Journal of Leukocyte Biology, vol. 69, no. 4, pp. 505–512, 2001. View at Google Scholar · View at Scopus
  8. M. Haroon and J. Devlin, “A case of ANCA-associated systemic vasculitis induced by atorvastatin,” Clinical Rheumatology, vol. 27, no. 2, supplement, pp. 75–77, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. F. Yu, M. Chen, Y. Gao et al., “Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis,” The American Journal of Kidney Diseases, vol. 49, no. 5, pp. 607–614, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. V. Talor, J. H. Stone, J. Stebbing, J. Barin, N. R. Rose, and C. L. Burek, “Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA),” Clinical and Experimental Immunology, vol. 150, no. 1, pp. 42–48, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. R. Kain, M. Exner, R. Brandes et al., “Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis,” Nature Medicine, vol. 14, no. 10, pp. 1088–1096, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. R. Kain, H. Tadema, E. F. McKinney et al., “High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis,” Journal of the American Society of Nephrology, vol. 23, no. 3, pp. 556–566, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. Haas and J. A. Eustace, “Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases,” Kidney International, vol. 65, no. 6, pp. 2145–2152, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. W. Y. Tse, A. J. Howie, D. Adu et al., “Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases,” Nephrology Dialysis Transplantation, vol. 12, no. 5, pp. 1017–1027, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Matsumoto, H. Honda, T. Shibata et al., “MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits,” NDT Plus, vol. 2, no. 6, pp. 461–465, 2009. View at Publisher · View at Google Scholar · View at Scopus